- Home
- PRA vs VCEL Comparison
PRA vs VCEL Comparison
Compare PRA & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRA
- VCEL
- Stock Information
- Founded
- PRA 1976
- VCEL 1989
- Country
- PRA United States
- VCEL United States
- Employees
- PRA N/A
- VCEL N/A
- Industry
- PRA Property-Casualty Insurers
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PRA Finance
- VCEL Health Care
- Exchange
- PRA Nasdaq
- VCEL Nasdaq
- Market Cap
- PRA 1.2B
- VCEL 2.1B
- IPO Year
- PRA N/A
- VCEL 1997
- Fundamental
- Price
- PRA $23.63
- VCEL $40.15
- Analyst Decision
- PRA Hold
- VCEL Strong Buy
- Analyst Count
- PRA 4
- VCEL 8
- Target Price
- PRA $21.00
- VCEL $62.00
- AVG Volume (30 Days)
- PRA 550.6K
- VCEL 430.8K
- Earning Date
- PRA 08-07-2025
- VCEL 07-31-2025
- Dividend Yield
- PRA N/A
- VCEL N/A
- EPS Growth
- PRA N/A
- VCEL 521.85
- EPS
- PRA 0.83
- VCEL 0.05
- Revenue
- PRA $1,140,267,000.00
- VCEL $238,541,000.00
- Revenue This Year
- PRA N/A
- VCEL $23.03
- Revenue Next Year
- PRA $1.25
- VCEL $24.52
- P/E Ratio
- PRA $28.57
- VCEL $705.61
- Revenue Growth
- PRA N/A
- VCEL 14.80
- 52 Week Low
- PRA $10.76
- VCEL $37.39
- 52 Week High
- PRA $23.73
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- PRA 76.83
- VCEL 44.33
- Support Level
- PRA $22.79
- VCEL $40.53
- Resistance Level
- PRA $22.88
- VCEL $43.57
- Average True Range (ATR)
- PRA 0.16
- VCEL 1.62
- MACD
- PRA 0.04
- VCEL -0.16
- Stochastic Oscillator
- PRA 133.82
- VCEL 28.65
About PRA ProAssurance Corporation
ProAssurance Corp is a holding company for property and casualty insurance companies. The company's wholly-owned insurance subsidiaries provide professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, and workers' compensation insurance. ProAssurance reports operating results in five segments: Specialty Property and Casualty, Workers' Compensation, Segregated Portfolio Cell Reinsurance, Lloyd's Syndicate, and Corporate. ProAssurance generates the vast majority of its revenue from its Specialty P&C activities, followed by Worker's Compensation.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.